These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 3409505
21. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. Golino P, Rosolowsky M, Yao SK, McNatt J, De Clerck F, Buja LM, Willerson JT. J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320 [Abstract] [Full Text] [Related]
27. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage. Kirchengast M, Rübsamen K, Lehmann HD. J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319 [Abstract] [Full Text] [Related]
28. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Willerson JT, Yao SK, McNatt J, Benedict CR, Anderson HV, Golino P, Murphree SS, Buja LM. Proc Natl Acad Sci U S A; 1991 Dec 01; 88(23):10624-8. PubMed ID: 1961728 [Abstract] [Full Text] [Related]
29. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Pakala R, Willerson JT, Benedict CR. Circulation; 1997 Oct 07; 96(7):2280-6. PubMed ID: 9337201 [Abstract] [Full Text] [Related]
30. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Bush LR, Campbell WB, Buja LM, Tilton GD, Willerson JT. Circulation; 1984 Jun 07; 69(6):1161-70. PubMed ID: 6546902 [Abstract] [Full Text] [Related]
32. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury. Beaughard M, Brasset M, John G, Massingham R. J Cardiovasc Pharmacol; 1995 Oct 07; 26(4):577-83. PubMed ID: 8569218 [Abstract] [Full Text] [Related]